Published: 10 February 2022
Author(s): Sofía Tejada, Marta Leal-dos-Santos, Yolanda Peña-López, Stijn Blot, Emine Alp, Jordi Rello
Issue: May 2022
Section: Original article

Central venous access devices are indispensable in modern healthcare but their use come with an inherent patient safety risk [1,2]. Catheter-associated bloodstream infections represent 10%-20% of all nosocomial infections [3], and central line-associated bloodstream infections (CLABSI) are associated with both over-hospitalization and additional costs [4]. Microorganisms can intraluminally access a central venous catheter via its hub, particularly in those containing propofol and parenteral nutrition [5].


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.